NYSE •
Healthcare •
Biotechnology •
Quote as of 08/14/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization506.4 mln
Float45.08 mln
Earnings Date11/16/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-3.19
Reliable
1-Year Forecast
7.00
Fairly priced
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
0.96
Moderate leverage
ROE
-57.14
Deeply negative
Business Description
Founded in 2008 and based in Boston, Ginkgo Bioworks helps companies across industries design and build living cells for practical use, from developing new drugs and agricultural solutions to improving food ingredients and industrial processes. Its platform combines automation, artificial intelligence, and genomic tools to make cell engineering faster and more accessible for research and commercial applications. The company also operates a biosecurity division that monitors environmental and biological threats through sensor networks and data analytics.
